Dermata Therapeutics Announces Preorders Open For Tome Foundational Treatment, Its First Direct-To-Consumer Skincare Product; Shipping Expected To Begin August 25

Dermata Therapeutics Announces $3.4M Private Placement Of 2,293,608 Shares And Warrants Priced At-The-Market At $1.46 Per Share

Dermata Therapeutics Stock Surges 27% Pre-Market: Why is it Moving?

Dermata Therapeutics shares jumped 28.73% pre-market after reporting second-quarter results and preparing for its upcoming skincare product launch.

Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket

CRWV shares rose in pre-market trading after reporting better-than-expected Q2 results. BAOS, BOXL, DOGZ, DRMA, ZBAO, HYLN, XHLD, VELO, and HRB also saw gains.